DNAnexus Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Private

  • Employees
  • 286

Employees

  • Latest Deal Type
  • Series I

  • Latest Deal Amount
  • $200M

  • Investors
  • 23

DNAnexus General Information

Description

Developer of a biomedical informatics and data management platform designed to analyze DNA-sequencing data. The company's platform assists researchers across a spectrum of industries like biopharmaceutical, bioagricultural, sequencing services, clinical diagnostics, government, and research consortia to accelerate their genomics programs globally, enabling commercial and academic medical researchers to visualize and analyze big data systems for DNA from a single, unified system.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1975 West El Camino Real
  • Suite 204
  • Mountain View, CA 94040
  • United States
+1 (650)
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Biotechnology
Other Healthcare Technology Systems
Vertical(s)
Digital Health, Artificial Intelligence & Machine Learning, HealthTech, Life Sciences
Corporate Office
  • 1975 West El Camino Real
  • Suite 204
  • Mountain View, CA 94040
  • United States
+1 (650)

DNAnexus Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

DNAnexus Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
12. Later Stage VC (Series I) 08-Mar-2022 $200M Completed Generating Revenue
11. Later Stage VC (Series H) 15-Mar-2021 Completed Generating Revenue
10. Later Stage VC (Series G) 06-Feb-2019 Completed Generating Revenue
9. Later Stage VC (Series F) 02-Jan-2018 Completed Generating Revenue
8. Later Stage VC (Series E) Completed Generating Revenue
7. Debt - General 01-May-2017 Completed Generating Revenue
6. Later Stage VC (Series D) 22-Apr-2015 Completed Generating Revenue
5. Debt - General 21-Mar-2014 Completed Generating Revenue
4. Later Stage VC (Series C) 03-Jan-2014 $15M $31.7M Completed Startup
3. Early Stage VC (Series B) 12-Oct-2011 $15.2M $16.7M Completed Startup
To view DNAnexus’s complete valuation and funding history, request access »

DNAnexus Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series I
Series H
Series G
Series F-2
Series F-1
Series E
Series D
Series C
Series B 7,559,292 $0.001000 $0.16 $2.02 $2.02 1x $0.63 2.37%
Series A 1,347,823 $0.001000 $0.09 $1.15 $1.15 1x $0.47 0.32%
To view DNAnexus’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

DNAnexus Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a biomedical informatics and data management platform designed to analyze DNA-sequencing data. The company'
Discovery Tools (Healthcare)
Mountain View, CA
286 As of 2024

San Francisco, CA
 

Foster City, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

DNAnexus Competitors (35)

One of DNAnexus’s 35 competitors is Benchling, a Venture Capital-Backed company based in San Francisco, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Benchling Venture Capital-Backed San Francisco, CA
PointCross Life Sciences Venture Capital-Backed Foster City, CA
SOPHiA GENETICS Formerly VC-backed Rolle, Switzerland
Gene By Gene Formerly VC-backed Houston, TX
BC Platforms Private Equity-Backed Zurich, Switzerland
You’re viewing 5 of 35 competitors. Get the full list »

DNAnexus Patents

DNAnexus Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20170237805-A1 Worker reuse deadline Inactive 12-Feb-2016
US-20170177597-A1 Biological data systems Inactive 22-Dec-2015
US-20140249761-A1 Characterizing uncharacterized genetic mutations Inactive 01-Mar-2013
US-20150331909-A1 Application programming interface for tabular genomic datasets Inactive 20-Dec-2012
US-20140244625-A1 Sequence read archive interface Inactive 12-Aug-2011 G16B50/00
To view DNAnexus’s complete patent history, request access »

DNAnexus Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

DNAnexus Investors (23)

Investor Name Investor Type Holding Investor Since Participating Rounds
Blackstone PE/Buyout Minority
Ally Bridge Group PE/Buyout Minority
Northpond Ventures Venture Capital Minority
Perceptive Advisors Venture Capital Minority
Regeneron Pharmaceuticals Corporation Minority
You’re viewing 5 of 23 investors. Get the full list »

DNAnexus FAQs

  • When was DNAnexus founded?

    DNAnexus was founded in 2009.

  • Where is DNAnexus headquartered?

    DNAnexus is headquartered in Mountain View, CA.

  • What is the size of DNAnexus?

    DNAnexus has 286 total employees.

  • What industry is DNAnexus in?

    DNAnexus’s primary industry is Discovery Tools (Healthcare).

  • Is DNAnexus a private or public company?

    DNAnexus is a Private company.

  • What is the current valuation of DNAnexus?

    The current valuation of DNAnexus is .

  • What is DNAnexus’s current revenue?

    The current revenue for DNAnexus is .

  • How much funding has DNAnexus raised over time?

    DNAnexus has raised $611M.

  • Who are DNAnexus’s investors?

    Blackstone, Ally Bridge Group, Northpond Ventures, Perceptive Advisors, and Regeneron Pharmaceuticals are 5 of 23 investors who have invested in DNAnexus.

  • Who are DNAnexus’s competitors?

    Benchling, PointCross Life Sciences, SOPHiA GENETICS, Gene By Gene, and BC Platforms are some of the 35 competitors of DNAnexus.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »